RESUMEN
Aims The aims of this study are to identify the proportion of ACS patients using an ambulance to transport to hospital and to explore the factors influencing mode of transport. Methods A retrospective, observational cohort design was utilised in this study. Data concerning cases of ACS in a university hospital over a 9-year period was obtained from the Coronary Heart Attack Ireland Register. Descriptive statistics were used to detail demographic and clinical data, as well as to establish the proportion of ambulance usage among ACS patients. Chi-square and t-tests were used to differentiate between groups at baseline. Factors influencing mode of transport were analysed by binary logistic regression. Results 4,229 cases were obtained. Exclusion and inclusion criteria were applied, leaving 1,964 cases for overall analysis. 533 (27%) patients directly used an ambulance, 1,098 (56%) patients presented initially to their GP while 333 (17%) went directly to A&E. Logistic regression showed that age, clinical factors, smoking status and diagnosis each had a statistically significant effect on ambulance usage. Conclusions Ambulance services are underutilised by ACS patients, despite clear benefits of their use. Several factors impacted patients' mode of transport. Knowledge of these is essential in guiding future awareness campaigns to promote ambulance usage in ACS.
Asunto(s)
Síndrome Coronario Agudo , Infarto del Miocardio , Síndrome Coronario Agudo/diagnóstico , Síndrome Coronario Agudo/terapia , Ambulancias , Humanos , Modelos Logísticos , Estudios RetrospectivosRESUMEN
Aims To evaluate the impact of Allura Clarity technology on radiation exposure in patients undergoing diagnostic coronary angiography. Methods A retrospective analysis was undertaken of invasive coronary angiograms performed by a single experienced operator in Cork University Hospital (CUH) (Allura Xper FD10 angiography system). In order to reduce operator variability, we also analysed cases performed by the same operator in the Bon Secours Hospital Cork (BSHC) (Allura Clarity FD10 angiography system). Cases were selected consecutively, having excluded those involving percutaneous coronary intervention, graft studies, aortography, ventriculography, right heart studies or fractional flow reserve studies. Results A total of 178 patients were included, equally distributed between the CUH arm (n=89) and the BSHC arm (n=89). Cohorts were very well matched in terms of age, gender, Body Mass Index, and procedural approach. The median radiation dose in CUH was a Dose Area Product (DAP) of 10,460 mGy.cm2 vs. median DAP of 12,795 mGy.cm2 in BSHC (p=0.148). The median fluoroscopy time in CUH was 2.25mins vs. median fluoroscopy time of 2.17mins in BSHC (p=0.675). Conclusion The use of the Allura Clarity system for diagnostic coronary angiography did not result in a significant difference in radiation dose or fluoroscopy time when compared to the reference Allura Xper system. Further research is needed to investigate the benefit of this new image noise reduction technology in diagnostic coronary angiography.
Asunto(s)
Reducción Gradual de Medicamentos , Reserva del Flujo Fraccional Miocárdico , Angiografía Coronaria/efectos adversos , Fluoroscopía/efectos adversos , Humanos , Dosis de Radiación , Estudios RetrospectivosRESUMEN
OBJECTIVES: We sought to estimate risk of poor self-rated health (SRH) following exposure to disability-related and other forms of overt discrimination in a cohort of working age adults. STUDY DESIGN: The study design is a population-based cohort survey. METHODS: Secondary analysis of data collected in Waves 1 and 2 of the UK's Life Opportunities Survey which at Wave 2 involved the participation of 12,789 working age adults. Adjusted prevalence rate ratios were used to estimate the impact of exposure to disability and non-disability discrimination on two measures of SRH at Wave 2, controlling for SRH status at Wave 1. RESULTS: Exposure to disability discrimination in the previous year was reported by 3.9% of working age British adults. Other forms of discrimination were reported less frequently (age: 3.7%, ethnicity: 2.5%, gender: 1.6%, religion: 0.8%, sexual orientation: 0.4%). In all analyses, there were stronger associations between exposure to disability discrimination and poor SRH at Wave 2 when compared with exposure to other forms of discrimination. CONCLUSIONS: Disability discrimination represents a violation of human rights. It is also likely to be a major contributor to the health inequities experienced by working age adults with disability.
Asunto(s)
Estado de Salud , Autoinforme , Discriminación Social , Adolescente , Adulto , Personas con Discapacidad , Etnicidad , Femenino , Humanos , Renta , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores Sexuales , Conducta Sexual , Encuestas y Cuestionarios , Reino Unido , Adulto JovenRESUMEN
OBJECTIVES: To examine perceptions of safety and exposure to violence in public places among working age adults with and without disabilities in the UK and to assess the extent to which any between-group differences may be moderated by gender and socio-economic situation. STUDY DESIGN: Cross-sectional study. METHODS: Secondary analysis of data collected in Wave 3 (2011-13) of Understanding Society. Data were extracted on a subsample of 5069 respondents aged 16 to 64 years (28% of whom had a disability/long-term health condition) who were administered a questionnaire module addressing experiences of harassment. Between-group comparisons were made on four self-reported indicators of safety. RESULTS: Respondents with disabilities/long-term health conditions were significantly more likely to have been attacked (adjusted OR 2.30, 95%CI 1.17-4.50, P < 0.05), insulted (adjusted OR 1.48, 95%CI 1.16-1.90, P < 0.01) and to feel unsafe in public places (adjusted OR 1.32, 95%CI 1.16-1.56, P < 0.01) over the previous 12 months. There were no statistically significant differences between groups with regard to self-reported avoidance of public places. These associations were moderated by both gender and poverty status, with the increased risk of exposure to violence among people with disabilities being greater for both women and people living in poverty. CONCLUSIONS: The data add further support to the growing evidence base suggesting that people with a disability/long-term health condition are at significantly increased risk of exposure to interpersonal violence, particularly if they are living in poverty or are women. As such, there is a clear need to develop interventions that are targeted to the particular circumstances and needs of these high risk groups.
Asunto(s)
Personas con Discapacidad/psicología , Exposición a la Violencia/estadística & datos numéricos , Instalaciones Públicas , Seguridad , Adolescente , Adulto , Estudios Transversales , Personas con Discapacidad/estadística & datos numéricos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pobreza , Autoinforme , Factores Sexuales , Reino Unido , Adulto JovenRESUMEN
Studies suggest an independent association between Obstructive Sleep Apnoea Syndrome (OSAS) and cardiovascular death. The purpose of our study is to examine doctors' awareness of this association and to determine whether this correlates with recording of OSAS on death certificates. We contacted the Central Statistics Office (CSO) and obtained relevant mention of OSAS on death certificates. We surveyed doctors on their view of OSAS-related deaths, CSO data from 2008-2011 reveal two deaths with OSAS documented as a direct cause and 52 deaths with OSAS as a contributory cause. Seventy-five doctors' surveyed (41%) believe OSAS can be a direct cause of death and 177 (96%) believe OSAS can be an indirect cause of death. Only 22 (12%) had putdown OSAS as a cause of death. OSAS is seldom recorded on death certificates. This is at odds with epidemiological forecasts and contrary to an opinion poll from a selection of doctors.
Asunto(s)
Médicos/psicología , Médicos/estadística & datos numéricos , Apnea Obstructiva del Sueño/mortalidad , Actitud del Personal de Salud , Recolección de Datos , Humanos , RiesgoRESUMEN
Obesity is a growing issue in Ireland. The link between obesity, CKD and CAD has not previously been described in the Irish population. The prevalence of obesity and CKD was compared across 3 groups: population based estimates with self-reported CAD, population based estimates without self-reported CAD (SLAN-07) and a random selection of cardiology outpatients with CAD. The SLAN-07 is a representative survey of 1207 randomly selected participants ≥ 45 years. Validated methods measured parameters including waist circumference, blood pressure and markers of renal function specifically glomerular filtration rate (eGFR) and albumin: creatinine ratio. The Cardiology clinic surveyed a random selection of 126 participants ≥ 45 years with CAD. Similar parameters were measured using the validated methods utilised in SLAN-07 study. Prevalence of obesity and renal disease was significantly higher in both CAD groups. At population level, risk factors were modelled using logistic regression to compare odds of participants with self-reported CAD with those without. Age, hypertension, obesity, elevated waist circumference, renal disease and diabetes are significantly associated with existing CAD. Obesity and CKD are more frequent in patients with CAD. Routine evaluation is essential to facilitate more intensive management of these risk factors.
Asunto(s)
Enfermedad de la Arteria Coronaria/epidemiología , Obesidad/epidemiología , Insuficiencia Renal Crónica/epidemiología , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Estudios Transversales , Femenino , Humanos , Hipertensión , Irlanda/epidemiología , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Prevalencia , Factores de Riesgo , AutoinformeRESUMEN
In Ireland, there are four anticoagulants available for prescribing to patients with atrial fibrillation for stroke prevention. A key feature of the three most recent anticoagulants is that monitoring is redundant. Despite this, there is continued prescribing of the incumbent anticoagulant, warfarin, which requires monitoring. Lack of information regarding the cost of monitoring, and the extra burden it places on health budgets and patients, motivated this costing study. Using micro costing, the costs of warfarin treatment (including monitoring) was disaggregated and isolated from both the patients' and health care provider's perspectives in a Cork hospital. Costs to the health care provider per patient per clinic visited were 21.57 Euros. Patient costs incurred per patient per clinic were 48.50 Euros. Thus, the total costs per patient per visit were 70.07 Euros. This result reveals that while the pharmaceutical cost of warfarin is low; it is not an inexpensive therapy when monitoring costs are considered.
Asunto(s)
Atención Ambulatoria/economía , Anticoagulantes/economía , Fibrilación Atrial/economía , Costos de los Medicamentos , Accidente Cerebrovascular/prevención & control , Warfarina/economía , Anciano , Instituciones de Atención Ambulatoria/economía , Anticoagulantes/uso terapéutico , Fibrilación Atrial/tratamiento farmacológico , Análisis Costo-Beneficio , Recolección de Datos , Monitoreo de Drogas/economía , Personal de Salud/economía , Humanos , Irlanda , Muestreo , Encuestas y Cuestionarios , Warfarina/uso terapéuticoRESUMEN
BACKGROUND: Older adults with diabetes in the hospital are generally managed similarly to younger adults, however, it is unknown if the degree of frailty can affect glucose control among hospitalized patients. METHODS: We examined glycemic parameters derived from continuous glucose monitoring (CGM) in older adults with type 2 diabetes and frailty who were hospitalized in non-acute settings. Data was pooled from 3 prospective studies using CGM including 97 patients wearing Libre CGM sensors and 166 patients wearing Dexcom G6 CGM. Glycemic parameters (time in range (TIR) 70-180; time below range (TBR) <70 and 54 mg/dl) by CGM were compared between 103 older adults ≥60 years and 168 younger adults <60 years. Frailty was assessed using validated laboratory and vital signs frailty index FI-LAB (n = 85), and its effect on hypoglycemia risk was studied. RESULTS: Older adults, as compared to younger adults, had significantly lower admission HbA1c (8.76% ± 1.82 vs. 10.25% ± 2.29, p < 0.001), blood glucose (203.89 ± 88.65 vs. 247.86 ± 124.17 mg/dl, p = 0.003), mean daily BG (173.9 ± 41.3 vs. 183.6 ± 45.0 mg/dl, p = 0.07) and higher percent TIR 70-180 mg/dl (59.0 ± 25.6% vs. 51.0 ± 26.1%, p = 0.02) during hospital stay. There was no difference in hypoglycemia occurrence between older and younger adults. Higher FI-LAB score was associated with higher % CGM < 70 mg/dl (0.204) and % CGM < 54 mg/dl (0.217). CONCLUSION: Older adults with type 2 diabetes have better glycemic control prior to admission and during hospital stay compared to younger adults. Frailty is associated with longer presence of hypoglycemia in non-acute hospital settings.
Asunto(s)
Diabetes Mellitus Tipo 1 , Diabetes Mellitus Tipo 2 , Fragilidad , Hipoglucemia , Humanos , Anciano , Glucemia , Pacientes Internos , Automonitorización de la Glucosa Sanguínea , Control Glucémico , Estudios Prospectivos , Hipoglucemia/prevención & control , Hipoglucemia/diagnóstico , Envejecimiento , Hipoglucemiantes , InsulinaRESUMEN
INTRODUCTION: The human papilloma virus (HPV) can cause laryngeal papillomatosis in childhood. The aetiology is thought to be vertical transmission. Clinically these children are usually asymptomatic for the first 6 months of life. As the papillomas develop locally, symptoms begin to develop. The symptoms range from voice change to frank hoarseness, and 'noisy' breathing, most commonly inspiratory stridor. METHOD: Clinical images from microlaryngoscopy and bronchoscopy over a 12-year period were assessed for laryngeal papilloma. RESULTS: In Leeds seven cases presented to the specialist centre over the past 12 years, the average age at presentation was 6.8 years and duration of onset of symptoms to specialist review was 21 months. Five of the children had been treated for asthma and two presented in extremis. CONCLUSION: The take home message for clinicians is hoarse voice associated with shortness of breath needs specialist referral.
Asunto(s)
Neoplasias Laríngeas/diagnóstico , Papiloma/diagnóstico , Broncoscopía , Niño , Disnea/etiología , Femenino , Ronquera/etiología , Humanos , Neoplasias Laríngeas/complicaciones , Laringoscopía , Masculino , Papiloma/complicacionesRESUMEN
PURPOSE: The aim of this study was to evaluate if men with varying degrees of bother from a similar number of nocturia episodes differ with respect to self-rated sleep characteristics and fatigue. MATERIALS AND METHODS: As part of the baseline assessments during a nocturia treatment trial, 55 participants reported frequency and bother of nocturia using the AUA Symptom Inventory and completed 7-day sleep diaries prior to treatment. Participants who reported moderate nocturia (either two or three episodes nightly) were further grouped into categories of LOW (nocturia is no problem or a very small problem) or HIGH bother (nocturia is a big problem). Information from the participant completed sleep diaries was abstracted, including information on daytime napping, total sleep time, mean time needed to return to sleep, nighttime ratings of fatigue, and daytime ratings of fatigue. RESULTS: Of the 55 individuals who completed the pilot study, 24 study participants reported two or three episodes of nocturia and had either HIGH (n = 11) or LOW (n = 13) bother. Participants categorised with HIGH bother were significantly more likely than those with LOW bother to report difficulty initiating sleep (47.7 ± 34.4 vs. 23.5 ± 13.6 min, p = 0.05), difficulty returning to sleep after an awakening (28.9 ± 16.1 vs. 15.4 ± 9.6 min, p = 0.03) and greater morning fatigue (3.3 ± 0.7 vs. 2.5 ± 1.0, p = 0.04 on a 7-point scale). CONCLUSIONS: Since bother related to nocturia is linked to sleep quality, interventions targeting fatigue and sleep maintenance may provide useful targets in the management of nocturia in men.
Asunto(s)
Fatiga/etiología , Nocturia/complicaciones , Trastornos del Sueño-Vigilia/etiología , Anciano , Autoevaluación Diagnóstica , Fatiga/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Nocturia/tratamiento farmacológico , Nocturia/fisiopatología , Proyectos Piloto , Calidad de Vida , Autoinforme , Trastornos del Inicio y del Mantenimiento del Sueño/etiología , Micción/fisiología , Urodinámica/fisiologíaRESUMEN
OBJECTIVE: External examination of a clinical risk score to predict persistent postconcussive symptoms (PPCS) in a pediatric emergency department (ED). METHODS: Prospective cohort study of 5- to 18-year-old patients diagnosed with an acute concussion. Risk factors were collected at diagnosis and participants (n = 85) were followed to determine PPCS 30 days postinjury. Univariate logistic regression analyses were completed to examine associations of risk factors with PPCS. RESULTS: Headache and total clinical risk score were associated with increased odds of PPCS in the univariate analyses, OR 3.37 (95% CI 1.02, 11.10) and OR 1.25 (95% CI 1.02, 1.52), respectively. Additionally, teenage age group, history of prolonged concussions, and risk group trended toward association with PPCS, OR 4.79 (95% CI 0.93, 24.7), OR 3.41 (95% CI 0.88, 13.20), and OR 2.23 (95% CI 0.88, 5.66), respectively. CONCLUSION: Our study supports the use of multiple variables of a clinical risk score to assist with ED risk stratification for pediatric patients at risk for PPCS.
Asunto(s)
Conmoción Encefálica , Síndrome Posconmocional , Adolescente , Conmoción Encefálica/complicaciones , Niño , Preescolar , Servicio de Urgencia en Hospital , Humanos , Pruebas Neuropsicológicas , Síndrome Posconmocional/diagnóstico , Síndrome Posconmocional/epidemiología , Síndrome Posconmocional/etiología , Estudios Prospectivos , Factores de RiesgoRESUMEN
The innervation of brown adipose tissue (BAT) by the sympathetic nervous system (SNS) is incontrovertible and, with its activation, functions as the principal, if not exclusive, stimulator of BAT thermogenesis. The parasympathetic innervation of BAT only appears in two minor BAT depots, but not in the major interscapular BAT (IBAT) depot. BAT thermogenesis is triggered by the release of norepinephrine from its sympathetic nerve terminals, stimulating ß3-adrenoceptors that turns on a cascade of intracellular events ending in activation of uncoupling protein-1 (UCP-1). BAT also has sensory innervation that may function to monitor BAT lipolysis, a response necessary for activation of UCP-1 by fatty acids, or perhaps responding in a feedback manner to BAT temperature changes. The central sympathetic outflow circuits ultimately terminating in BAT have been revealed by injecting the retrograde viral transneuronal tract tracer, pseudorabies virus, into the tissue; moreover, there is a high degree of colocalization of melanocortin 4-receptor mRNA on these neurons across the neural axis. The necessary and sufficient central BAT SNS outflow sites that are activated by various thermogenic stimuli are not precisely known. In a chronic decerebration procedure, IBAT UCP-1 gene expression can be triggered by fourth ventricular injections of melanotan II, the melanocortin 3/4 receptor agonist, suggesting that there is sufficient hindbrain neural circuitry to generate thermogenic responses with this stimulation. The recent recognition of BAT in normal adult humans suggests a potential target for stimulation of energy expenditure by BAT to help mitigate increased body fat storage.
Asunto(s)
Tejido Adiposo Pardo/inervación , Canales Iónicos/fisiología , Proteínas Mitocondriales/fisiología , Sistema Nervioso Simpático/fisiología , Termogénesis/fisiología , Tejido Adiposo Pardo/fisiología , Animales , Humanos , Canales Iónicos/genética , Proteínas Mitocondriales/genética , Proteína Desacopladora 1RESUMEN
Norepinephrine (NE) released from the sympathetic nerves innervating white adipose tissue (WAT) is the principal initiator of lipolysis in mammals. Central WAT sympathetic outflow neurons express melanocortin 4-receptor (MC4-R) mRNA. Single central injection of melanotan II (MTII; MC3/4-R agonist) nonuniformly increases WAT NE turnover (NETO), increases interscapular brown adipose tissue (IBAT) NETO, and increases the circulating lipolytic products glycerol and free fatty acid. The WAT pads that contributed to this lipolysis were inferred from the increases in NETO. Because phosphorylation of perilipin A (p-perilipin A) and hormone-sensitive lipase are necessary for NE-triggered lipolysis, we tested whether MTII would increase these intracellular markers of lipolysis. Male Siberian hamsters received a single 3rd ventricular injection of MTII or saline. Trunk blood was collected at 0.5, 1.0, and 2.0 h postinjection from excised inguinal, retroperitoneal, and epididymal WAT (IWAT, RWAT, and EWAT, respectively) and IBAT pads. MTII increased circulating glycerol concentrations at 0.5 and 1.0 h, whereas free fatty acid concentrations were increased at 1.0 and 2.0 h. Western blot analysis showed that MTII specifically increased p-perilipin A and hormone-sensitive lipase only in fat pads that previously had MTII-induced increases in NETO. Phosphorylation increased in IWAT at all time points and IBAT at 0.5 h, but not RWAT or EWAT at any time point. These results show for the first time in rodents that p-perilipin A can serve as an in vivo, fat pad-specific indictor of lipolysis and extend our previous findings showing that central melanocortin stimulation increases WAT lipolysis.
Asunto(s)
Tejido Adiposo/metabolismo , Lipólisis/fisiología , Tejido Adiposo/inervación , Tejido Adiposo/fisiología , Tejido Adiposo Pardo/metabolismo , Tejido Adiposo Blanco/metabolismo , Animales , Proteínas Portadoras , Estimulantes del Sistema Nervioso Central/metabolismo , Cricetinae , Epidídimo/metabolismo , Ácidos Grasos no Esterificados/sangre , Ácidos Grasos no Esterificados/metabolismo , Glicerol/sangre , Glicerol/metabolismo , Masculino , Melanocortinas/metabolismo , Norepinefrina/sangre , Norepinefrina/metabolismo , Péptidos Cíclicos , Perilipina-1 , Phodopus , Fosfoproteínas , Fosforilación , Receptor de Melanocortina Tipo 4/genética , Receptor de Melanocortina Tipo 4/metabolismo , Esterol Esterasa/metabolismo , Sistema Nervioso Simpático/metabolismo , Sistema Nervioso Simpático/fisiología , alfa-MSH/análogos & derivadosRESUMEN
OBJECTIVE: The aim of this study was to examine the association of nocturia with incident falls in a population-based sample of community-dwelling elderly persons. METHODS: The University of Alabama at Birmingham Study of Aging is a prospective cohort study of 1000 community-dwelling older adults in the USA designed to examine factors associated with impaired mobility. Subjects were recruited from a stratified, random sample of Medicare beneficiaries to include equal numbers of black women, black men, white women and white men. Nocturia was assessed at baseline and falls were assessed at baseline and every 6 months for a total of 36 months of follow-up. RESULTS: A total of 692 individuals (mean age 74.5 +/- 6.2, 48% female, 52% black) did not fall in the 12 months prior to baseline. Of these 692, 214 (30.9%) reported falling at least once during the subsequent 3 years. In unadjusted analysis, three or more nightly episodes of nocturia were associated with an incident fall [RR = 1.27, 95% CI (1.01-1.60)]. After multivariable logistic regression, three or more episodes of nocturia were associated with an increased risk of falling [RR = 1.28, (1.02-1.59)]. DISCUSSION: In a racially diverse, community-based sample of older men and women who had not fallen in the previous year, nocturia three or more times a night was associated in multivariable analysis with a 28% increased risk of an incident fall within 3 years. While this study has several advantages over previous reports (longitudinal follow-up, performance-based measures of function, population-based sampling), causality cannot be ascertained. Further research is needed to ascertain the impact of treatments to reduce nocturia as part of a multi-component programme to reduce fall risk.
Asunto(s)
Accidentes por Caídas/estadística & datos numéricos , Nocturia/complicaciones , Distribución por Edad , Anciano , Anciano de 80 o más Años , Alabama/epidemiología , Femenino , Humanos , Masculino , Nocturia/epidemiología , Estudios ProspectivosRESUMEN
Neurotensin modulates pain via its actions within descending analgesic pathways which include brain regions such as the midbrain periaqueductal grey (PAG). The aim of this study was to examine the cellular actions of neurotensin on PAG neurons. Whole cell patch clamp recordings were made from rat midbrain PAG slices in vitro to examine the postsynaptic effects of neurotensin and its effects on GABA(A) mediated inhibitory postsynaptic currents (IPSCs). Neurotensin (100-300 nM) produced an inward current in subpopulations of opioid sensitive and insensitive PAG neurons which did not reverse over membrane potentials between -50 and -130 mV. The neurotensin induced current was abolished by the NTS1 and NTS1/2 antagonists SR48692 (300 nM) and SR142948A (300 nM). Neurotensin also produced a reduction in the amplitude of evoked IPSCs, but had no effect on the rate and amplitude of TTX-resistant miniature IPSCs. The neurotensin induced inhibition of evoked IPSCs was reduced by the mGluR5 antagonist MPEP (5microM) and abolished by the cannabinoid CB(1) receptor antagonist AM251 (3 microM). These results suggest that neurotensin produces direct neuronal depolarisation via NTS1 receptors and inhibits GABAergic synaptic transmission within the PAG. The inhibition of synaptic transmission is mediated by neuronal excitation and action potential dependent release of glutamate, leading to mGluR5 mediated production of endocannabinoids which activate presynaptic CB(1) receptors. Thus, neurotensin has cellular actions within the PAG which are consistent with both algesic and analgesic activity, some of which are mediated via the endocannabinoid system.
Asunto(s)
Moduladores de Receptores de Cannabinoides/metabolismo , Endocannabinoides , Inhibición Neural , Neuronas/metabolismo , Neurotensina/metabolismo , Sustancia Gris Periacueductal/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Transmisión Sináptica , Ácido gamma-Aminobutírico/metabolismo , Adamantano/análogos & derivados , Adamantano/farmacología , Animales , Antagonistas de Aminoácidos Excitadores/farmacología , Femenino , Imidazoles/farmacología , Técnicas In Vitro , Potenciales Postsinápticos Inhibidores , Masculino , Potenciales Postsinápticos Miniatura , Inhibición Neural/efectos de los fármacos , Neuronas/efectos de los fármacos , Dolor/metabolismo , Dolor/prevención & control , Sustancia Gris Periacueductal/citología , Sustancia Gris Periacueductal/efectos de los fármacos , Piperidinas/farmacología , Terminales Presinápticos/metabolismo , Pirazoles/farmacología , Piridinas/farmacología , Quinolinas/farmacología , Ratas , Ratas Sprague-Dawley , Receptor Cannabinoide CB1/antagonistas & inhibidores , Receptor Cannabinoide CB1/metabolismo , Receptor del Glutamato Metabotropico 5 , Receptores de Neurotensina/antagonistas & inhibidores , Receptores de Neurotensina/metabolismo , Transmisión Sináptica/efectos de los fármacos , Tetrodotoxina/farmacología , Factores de TiempoRESUMEN
This paper presents a mathematical tissue-equivalent breast phantom for linear slot-scanning digital mammography. A recently developed prototype linear slot-scanning digital mammography system was used for model validation; image quality metrics such as image contrast and contrast-to-noise ratio were calculated. The results were in good agreement with values measured using a physical breast-equivalent phantom designed for mammography. The estimated pixel intensity of the mathematical phantom, the analogue-to-digital conversion gain and the detector additive noise showed good agreement with measured values with correlation of nearly 1. An application of the model, to examine the feasibility of using a monochromatic filter for dose reduction and improvement of image quality in slot-scanning digital mammography, is presented.
Asunto(s)
Mama/citología , Mamografía/instrumentación , Modelos Biológicos , Fantasmas de Imagen , Intensificación de Imagen Radiográfica/instrumentación , Estudios de Factibilidad , Procesamiento de Imagen Asistido por Computador , Dosis de Radiación , Programas InformáticosRESUMEN
Excessive knee joint laxity is often used as an indicator of joint disease or injury. Clinical assessment devices are currently limited to anterior-posterior drawer measurements, while tools used to measure movement in the remaining degrees of freedom are either invasive or prone to soft tissue artefact. The objective of this work was, therefore, to develop a methodology whereby in vivo knee joint kinematics could be measured in three dimensions under torsional loading while still maintaining a non-invasive procedure. A device designed to administer a subject-normalized torque in the transverse plane of the knee was securely fastened to the outer frame of an open magnetic resonance imaging (MRI) magnet. Low resolution 3D T1-weighted images (6.25 mm slice thickness) were generated by the 0.2 Tesla MRI scanner in less than 3 min while the joint was under load. The 3D image volume was then shape-matched to a high resolution image volume (1.56 mm slice thickness) scanned in a no-load position. Three-dimensional rotations and translations of the tibia with respect to the femur were calculated by comparing the transformation matrices before and after torque was applied. Results from six subjects showed that this technique was repeatable over five trials with the knee in extended and flexed positions. Differences in range of rotation were shown between subjects and between knee positions, suggesting that this methodology has sufficient utility for further application in clinical studies.
Asunto(s)
Rodilla/fisiología , Adulto , Fenómenos Biomecánicos , Femenino , Humanos , Masculino , Tibia/fisiología , Torsión Mecánica , Soporte de Peso/fisiologíaRESUMEN
OBJECTIVE: To (a) identify post-concussion symptom scales appropriate for children and adolescents in sports; (b) review evidence for reliability and validity; and (c) recommend future directions for scale development. DESIGN: Quantitative and qualitative literature review of symptom rating scales appropriate for children and adolescents aged 5 to 22 years. INTERVENTION: Literature identified via search of Medline, Ovid-Medline and PsycInfo databases; review of reference lists in identified articles; querying sports concussion specialists. 29 articles met study inclusion criteria. RESULTS: 5 symptom scales examined in 11 studies for ages 5-12 years and in 25 studies for ages 13-22. 10 of 11 studies for 5-12-year-olds presented validity evidence for three scales; 7 studies provided reliability evidence for two scales; 7 studies used serial administrations but no reliable change metrics. Two scales included parent-reports and one included a teacher report. 24 of 25 studies for 13-22 year-olds presented validity evidence for five measures; seven studies provided reliability evidence for four measures with 18 studies including serial administrations and two examining Reliable Change. CONCLUSIONS: Psychometric evidence for symptom scales is stronger for adolescents than for younger children. Most scales provide evidence of concurrent validity, discriminating concussed and non-concussed groups. Few report reliability and evidence for validity is narrow. Two measures include parent/teacher reports. Few scales examine reliable change statistics, limiting interpretability of temporal changes. Future studies are needed to fully define symptom scale psychometric properties with the greatest need in younger student-athletes.
Asunto(s)
Traumatismos en Atletas/diagnóstico , Síndrome Posconmocional/diagnóstico , Índice de Severidad de la Enfermedad , Adolescente , Lista de Verificación/métodos , Niño , Preescolar , Predicción , Estado de Salud , Humanos , Psicometría , Reproducibilidad de los Resultados , Autorrevelación , Encuestas y Cuestionarios , Enseñanza , Adulto JovenRESUMEN
OBJECTIVE: The aim of this study was to investigate the kinetics, kinematics and muscle activity in runners with Achilles tendinopathy. DESIGN: Case-control study. SETTING: Biomechanics laboratory. PARTICIPANTS: 21 runners free from injury and 21 runners with Achilles tendinopathy performed 10 running trials with standardised running shoes. Injured runners were diagnosed clinically according to established diagnostic criteria. Uninjured runners had been injury-free for at least 2 years. MAIN OUTCOME MEASUREMENTS: During each trial, kinetic and lower limb kinematic data were measured using a strain gauge force plate and six infrared cameras respectively. Electromyographic (EMG) data from six muscles (tibialis anterior (TA), peroneus longus (PE), lateral gastrocnemius (LG), rectus femoris (RF), biceps femoris (BF) and gluteus medius (GM)) were measured with a telemetric EMG system. RESULTS: Knee range of motion (heel strike to midstance) was significantly lower in injured runners than in uninjured runners. Similarly, preactivation (integrated EMG (IEMG) in 100 ms before heel strike) of TA was lower for injured runners than uninjured runners. RF and GM IEMG activity 100 ms after heel strike was also lower in the injured group. However, impact forces were not different between the two groups. CONCLUSION: Altered knee kinematics and reduced muscle activity are associated with Achilles tendinopathy in runners. Rehabilitation exercises or other mechanisms (e.g. footwear) that affect kinematics and muscle activity may therefore be beneficial in the treatment of runners with Achilles tendinopathy.
Asunto(s)
Tendón Calcáneo/fisiopatología , Músculo Esquelético/fisiopatología , Carrera/fisiología , Tendinopatía/fisiopatología , Tendón Calcáneo/lesiones , Adulto , Fenómenos Biomecánicos/fisiología , Estudios de Casos y Controles , Electromiografía , Terapia por Ejercicio/métodos , Femenino , Humanos , Articulación de la Rodilla/fisiopatología , Masculino , Rango del Movimiento Articular/fisiología , Carrera/lesiones , Tendinopatía/rehabilitaciónRESUMEN
Of the chemicals identified to date in mainstream cigarette smoke with known toxicological properties, the volatile organic compounds (VOCs) are considered the most hazardous group owing to their high abundance and toxicity. In this research we evaluate a recently introduced line of cigarettes that contain charcoal in their filters. The amount of charcoal in these filters ranged from 45 mg to 180 mg and were either dispersed among the filter material or contained in a small cavity in the filter segment. Charcoal has long been used for removing VOCs from both water and air. Our findings indicate that these cigarettes reduce machine generated mainstream smoke deliveries of a wide range of VOCs compared to a similar, non-charcoal filtered, cigarette. However, this reduction is dependent not only on the amount of charcoal present but also on the volume of smoke being drawn through the filter. While a brand with 45 mg charcoal reduces VOC delivery under ISO smoking conditions, charcoal saturation and breakthrough occur under more intense smoking conditions. Breakthrough is minimised for brands with the most charcoal. Overall, the brands with the most charcoal are effective at reducing VOC deliveries under even intense smoking conditions.